Carter M. Suryadevara

Duke Brain Tumor Immunotherapy Program,
Department of Neurosurgery,
Department of Pathology,
Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery

Duke University

BIOGRAPHY

Carter M. Suryadevara has not added Biography.

If you are Carter M. Suryadevara and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Intracerebral delivery of a third generation EGFRvIII-specific chimeric antigen receptor is efficacious against human glioma.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia Jan, 2014 | Pubmed ID: 24054399

EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.

Clinical cancer research : an official journal of the American Association for Cancer Research Feb, 2014 | Pubmed ID: 24352643

EGFRvIII-specific chimeric antigen receptor T cells migrate to and kill tumor deposits infiltrating the brain parenchyma in an invasive xenograft model of glioblastoma.

PloS one , 2014 | Pubmed ID: 24722266

Epidermal growth factor receptor and variant III targeted immunotherapy.

Neuro-oncology Oct, 2014 | Pubmed ID: 25342601

Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.

Oncoimmunology , 2014 | Pubmed ID: 25610727

Chimeric antigen receptor engineered T cells can eliminate brain tumors and initiate long-term protection against recurrence.

Oncoimmunology , 2014 | Pubmed ID: 25610729

INSTITUTIONS

Duke University

JOVE ARTICLES

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Katherine Riccione^1,2,

Carter M. Suryadevara^1,3,

David Snyder¹,

Xiuyu Cui¹,

John H. Sampson^1,2,3,

Luis Sanchez-Perez¹

¹Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery, Duke University,

²Department of Biomedical Engineering, Duke University,

³Department of Pathology, Duke University

Immunology and Infection

政策

使用条款

隐私

联系我们

向图书馆推荐

JoVE 新闻简报

科研

JoVE Journal
技术专题合集
JoVE Encyclopedia of Experiments
档案

教育

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
教师资源中心
Faculty Site

发表

概述
发表流程
编辑部
范围和政策
同行评审
常见问题
提交稿件

图书馆员

概述
客户评价
订阅
访问权限
资源
图书馆咨询委员会
常见问题

关于 JoVE

概述
管理层
博客
JoVE Help Center

Carter M. Suryadevara

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Duke Brain Tumor Immunotherapy Program,Department of Neurosurgery,Department of Pathology,Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery

Duke University

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Duke Brain Tumor Immunotherapy Program,
Department of Neurosurgery,
Department of Pathology,
Duke Brain Tumor Immunotherapy Program, Department of Neurosurgery